- Home
- IFRX vs NEOV Comparison
IFRX vs NEOV Comparison
Compare IFRX & NEOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IFRX
- NEOV
- Stock Information
- Founded
- IFRX 2007
- NEOV 2018
- Country
- IFRX Germany
- NEOV United States
- Employees
- IFRX N/A
- NEOV N/A
- Industry
- IFRX Biotechnology: Pharmaceutical Preparations
- NEOV Industrial Machinery/Components
- Sector
- IFRX Health Care
- NEOV Miscellaneous
- Exchange
- IFRX Nasdaq
- NEOV Nasdaq
- Market Cap
- IFRX 65.8M
- NEOV 72.2M
- IPO Year
- IFRX 2017
- NEOV N/A
- Fundamental
- Price
- IFRX $1.30
- NEOV $2.69
- Analyst Decision
- IFRX Strong Buy
- NEOV Strong Buy
- Analyst Count
- IFRX 2
- NEOV 1
- Target Price
- IFRX $9.00
- NEOV $7.50
- AVG Volume (30 Days)
- IFRX 322.6K
- NEOV 148.6K
- Earning Date
- IFRX 05-07-2025
- NEOV 05-09-2025
- Dividend Yield
- IFRX N/A
- NEOV N/A
- EPS Growth
- IFRX N/A
- NEOV N/A
- EPS
- IFRX N/A
- NEOV N/A
- Revenue
- IFRX $171,642.00
- NEOV $2,524,931.00
- Revenue This Year
- IFRX $106.72
- NEOV $85.10
- Revenue Next Year
- IFRX $66.89
- NEOV $281.25
- P/E Ratio
- IFRX N/A
- NEOV N/A
- Revenue Growth
- IFRX 162.79
- NEOV N/A
- 52 Week Low
- IFRX $0.82
- NEOV $1.80
- 52 Week High
- IFRX $2.82
- NEOV $6.11
- Technical
- Relative Strength Index (RSI)
- IFRX 58.32
- NEOV 60.83
- Support Level
- IFRX $0.82
- NEOV $1.88
- Resistance Level
- IFRX $1.12
- NEOV $2.19
- Average True Range (ATR)
- IFRX 0.13
- NEOV 0.26
- MACD
- IFRX 0.06
- NEOV 0.08
- Stochastic Oscillator
- IFRX 90.49
- NEOV 86.76
About IFRX InflaRx N.V.
InflaRx NV is a clinical-stage biopharmaceutical company focused on applying proprietary anti-C5a/C5aR technology to discover and develop first-in-class, potent, and specific inhibitors of the complement activation factor known as C5a and its receptor known as C5aR. C5a is an inflammatory mediator involved in the progression of a wide variety of autoimmune and other inflammatory diseases. Its product candidate, vilobelimab, is a novel intravenously delivered first-in-class anti-C5a monoclonal antibody that selectively binds to free C5a and has demonstrated disease-modifying clinical activity and tolerability in multiple clinical settings.
About NEOV NeoVolta Inc.
NeoVolta Inc is engaged in designing, manufacturing and sale of high end Energy Storage System which can store and use solar energy via batteries and an inverter at a residential site. Its market place includes solar industry, installers, new construction homebuilders, home remodelers and homeowners.